chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Sweating; Body aches; chills; slight arm soreness; little fever/had low grade fever 100/102.7; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating), PYREXIA (little fever/had low grade fever 100/102.7), PAIN (Body aches), CHILLS (chills) and VACCINATION SITE PAIN (slight arm soreness) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029LL0A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LISINOPRIL, LEVOTHYROXINE and ALENDRONATE SODIUM (ALENDRONATE) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (little fever/had low grade fever 100/102.7) and VACCINATION SITE PAIN (slight arm soreness). On 22-Jan-2021, the patient experienced HYPERHIDROSIS (Sweating), PAIN (Body aches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 23-Jan-2021, HYPERHIDROSIS (Sweating), PYREXIA (little fever/had low grade fever 100/102.7), PAIN (Body aches), CHILLS (chills) and VACCINATION SITE PAIN (slight arm soreness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 100 (High) High and 102.7 (High) High. On 22-Jan-2021, COVID-19: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Paraesthesia, Pruritus, Rash
Clinical narrative: Tingly in the arm; Warmness in the arm; Itching; Rash on the arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingly in the arm), FEELING HOT (Warmness in the arm), PRURITUS (Itching) and RASH (Rash on the arm) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PARAESTHESIA (Tingly in the arm), FEELING HOT (Warmness in the arm), PRURITUS (Itching) and RASH (Rash on the arm). At the time of the report, PARAESTHESIA (Tingly in the arm), FEELING HOT (Warmness in the arm), PRURITUS (Itching) and RASH (Rash on the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 92.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Rash erythematous, Rash vesicular
Clinical narrative: Sore arm; Large red rash with blister in the center; Large red rash with blister in the center; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), RASH ERYTHEMATOUS (Large red rash with blister in the center) and RASH VESICULAR (Large red rash with blister in the center) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030m20a) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (Sore arm), RASH ERYTHEMATOUS (Large red rash with blister in the center) and RASH VESICULAR (Large red rash with blister in the center). At the time of the report, PAIN IN EXTREMITY (Sore arm), RASH ERYTHEMATOUS (Large red rash with blister in the center) and RASH VESICULAR (Large red rash with blister in the center) outcome was unknown.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-103611 (Linked Report). This case was linked to MOD-2021-103611 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Follow-up information received on 20-Apr-2021 included no new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-103611:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: little red pimple like rashes showing up and resolving; This spontaneous case was reported by a consumer and describes the occurrence of RASH (little red pimple like rashes showing up and resolving) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20A and 028L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL TARTRATE (LOPRESSOR), ATORVASTATIN and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced RASH (little red pimple like rashes showing up and resolving). At the time of the report, RASH (little red pimple like rashes showing up and resolving) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination complication, Vaccination site erythema, Vaccination site pain
Clinical narrative: soreness in the crease between left arm and back, soreness is about quarter inch/really hurts; injection site pain; aches; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (soreness in the crease between left arm and back, soreness is about quarter inch/really hurts), VACCINATION SITE PAIN (injection site pain), MYALGIA (aches) and VACCINATION SITE ERYTHEMA (red) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced VACCINATION COMPLICATION (soreness in the crease between left arm and back, soreness is about quarter inch/really hurts), VACCINATION SITE PAIN (injection site pain), MYALGIA (aches) and VACCINATION SITE ERYTHEMA (red). On 27-Jan-2021, VACCINATION SITE PAIN (injection site pain) and MYALGIA (aches) had resolved. At the time of the report, VACCINATION COMPLICATION (soreness in the crease between left arm and back, soreness is about quarter inch/really hurts) and VACCINATION SITE ERYTHEMA (red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  The treatment information was unknown.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Sore to touch; Itchiness; Red mark/Small oval patch of redness and Increased its size until reached elbow/Outer part of arm was red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness), VACCINATION SITE ERYTHEMA (Red mark/Small oval patch of redness and Increased its size until reached elbow/Outer part of arm was red) and VACCINATION SITE PAIN (Sore to touch) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 1994, Hypertension since 1994, Hypercholesterolemia since 1994 and Glaucoma since 2004. Concomitant products included LEVOTHYROXINE, TIMOLOL MALEATE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ), ROSUVASTATIN CALCIUM (ROSUVASTIN), ROSUVASTATIN CALCIUM (CRESTOR), VITAMIN B12 NOS, CARTILAGE, HYALURONIC ACID (MOVE FREE ULTRA), VITAMIN D NOS, LACTOBACILLUS BREVIS, LACTOBACILLUS BUCHNERI (FLORA BALANCE), LINUM USITATISSIMUM SEED OIL (FLAX SEED OIL) and UBIDECARENONE (CO Q10) for an unknown indication.    On 10-Feb-2021 at 5:25 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE ERYTHEMA (Red mark/Small oval patch of redness and Increased its size until reached elbow/Outer part of arm was red). On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore to touch). At the time of the report, VACCINATION SITE PRURITUS (Itchiness) and VACCINATION SITE PAIN (Sore to touch) outcome was unknown and VACCINATION SITE ERYTHEMA (Red mark/Small oval patch of redness and Increased its size until reached elbow/Outer part of arm was red) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood pressure pill, Advil as needed, Citracal as 1 tablet thrice a week, Vitamin C 100 milligram 1 tablet daily, Centrum silver 1 tablet once daily, Omega 3 1200milligram  gel once per day.  Treatment medication were not provided.    Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow-up received on 06-JUL-2021 contains no significant information On 16-Jul-2021: Added patients demographics, added patients medical history, added first and second dose details, added concomitant medication, updated event outcome
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Arthritis, Asthenia, Body temperature increased, Chills
Clinical narrative: Joints all inflamed; Ears are bothering; Joints are hurting; Chills really bad; Horrible headache; Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high; Rash where the injection was; Started feeling really sick; Dizziness; Weakness; Shortness of breath; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (Started feeling really sick), DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath) and ARTHRITIS (Joints all inflamed) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced MALAISE (Started feeling really sick), HEADACHE (Horrible headache) and PYREXIA (Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high). 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath) and VACCINATION SITE RASH (Rash where the injection was). On an unknown date, the patient experienced ARTHRITIS (Joints all inflamed), EAR DISCOMFORT (Ears are bothering), ARTHRALGIA (Joints are hurting) and CHILLS (Chills really bad). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MALAISE (Started feeling really sick), DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joints all inflamed), EAR DISCOMFORT (Ears are bothering), ARTHRALGIA (Joints are hurting), CHILLS (Chills really bad) and VACCINATION SITE RASH (Rash where the injection was) outcome was unknown, HEADACHE (Horrible headache) had not resolved and PYREXIA (Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature increased: 102 (High) Got really high up to 102 F on Saturday night.. On 21-Feb-2021, Body temperature increased: 100 (Inconclusive) On Sunday 21st the temperature got to 100 F.. On 22-Feb-2021, Body temperature increased: (Inconclusive) Monday 22nd still has temperature but not as high..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Ear discomfort, Headache, Malaise
Clinical narrative: Joints all inflamed; Ears are bothering; Joints are hurting; Chills really bad; Horrible headache; Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high; Rash where the injection was; Started feeling really sick; Dizziness; Weakness; Shortness of breath; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (Started feeling really sick), DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath) and ARTHRITIS (Joints all inflamed) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced MALAISE (Started feeling really sick), HEADACHE (Horrible headache) and PYREXIA (Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high). 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath) and VACCINATION SITE RASH (Rash where the injection was). On an unknown date, the patient experienced ARTHRITIS (Joints all inflamed), EAR DISCOMFORT (Ears are bothering), ARTHRALGIA (Joints are hurting) and CHILLS (Chills really bad). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MALAISE (Started feeling really sick), DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joints all inflamed), EAR DISCOMFORT (Ears are bothering), ARTHRALGIA (Joints are hurting), CHILLS (Chills really bad) and VACCINATION SITE RASH (Rash where the injection was) outcome was unknown, HEADACHE (Horrible headache) had not resolved and PYREXIA (Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature increased: 102 (High) Got really high up to 102 F on Saturday night.. On 21-Feb-2021, Body temperature increased: 100 (Inconclusive) On Sunday 21st the temperature got to 100 F.. On 22-Feb-2021, Body temperature increased: (Inconclusive) Monday 22nd still has temperature but not as high..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site rash
Clinical narrative: Joints all inflamed; Ears are bothering; Joints are hurting; Chills really bad; Horrible headache; Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high; Rash where the injection was; Started feeling really sick; Dizziness; Weakness; Shortness of breath; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (Started feeling really sick), DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath) and ARTHRITIS (Joints all inflamed) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-Feb-2021, the patient experienced MALAISE (Started feeling really sick), HEADACHE (Horrible headache) and PYREXIA (Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high). 20-Feb-2021, the patient experienced DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath) and VACCINATION SITE RASH (Rash where the injection was). On an unknown date, the patient experienced ARTHRITIS (Joints all inflamed), EAR DISCOMFORT (Ears are bothering), ARTHRALGIA (Joints are hurting) and CHILLS (Chills really bad). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, MALAISE (Started feeling really sick), DIZZINESS (Dizziness), ASTHENIA (Weakness), DYSPNOEA (Shortness of breath), ARTHRITIS (Joints all inflamed), EAR DISCOMFORT (Ears are bothering), ARTHRALGIA (Joints are hurting), CHILLS (Chills really bad) and VACCINATION SITE RASH (Rash where the injection was) outcome was unknown, HEADACHE (Horrible headache) had not resolved and PYREXIA (Running mild temperature that got really high up to 102 F/On Sunday 21st the temperature got to 100 F/ On Monday 22nd still has temperature but not as high) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature increased: 102 (High) Got really high up to 102 F on Saturday night.. On 21-Feb-2021, Body temperature increased: 100 (Inconclusive) On Sunday 21st the temperature got to 100 F.. On 22-Feb-2021, Body temperature increased: (Inconclusive) Monday 22nd still has temperature but not as high..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Drug interaction
Clinical narrative: Vaccine-Drug interaction; This spontaneous case was reported by a consumer and describes the occurrence of DRUG INTERACTION (Vaccine-Drug interaction) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Previously administered products included for an unreported indication: STEROIDS (Patient mentioned that he has been taking steroids for the past week and today is the last day.).    On 26-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced DRUG INTERACTION (Vaccine-Drug interaction). At the time of the report, DRUG INTERACTION (Vaccine-Drug interaction) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Hyperhidrosis, Influenza like illness
Clinical narrative: Flu like symptoms; Sweating; Chills; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (Sweating), CHILLS (Chills) and FATIGUE (Tiredness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (Sweating), CHILLS (Chills) and FATIGUE (Tiredness). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (Sweating), CHILLS (Chills) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided No Treatment information provided   This case was linked to MOD-2021-045543 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Mar-2021: No specific follow-up information recorded.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: a swollen lymph node on my collar bone; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (a swollen lymph node on my collar bone) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced LYMPHADENOPATHY (a swollen lymph node on my collar bone). At the time of the report, LYMPHADENOPATHY (a swollen lymph node on my collar bone) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rash arm; itch; A Spontaneous report was received from consumer  concerning a 66-year-old, female patient , who received first dose of Modern's COVID-19 vaccine(mRNA 1273) and experienced itching and rash. The patient medical history was not provided by the reporter. Concomitant medications were not provided not provided by the reporter. On 13-FEB-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273(042L20A) , via intramuscular  route and unknown anatomical location for prophylaxis of COVID-19 infection.  After receiving the first dose ,patient experienced itching and rash. Patient had taken Antiitch-lotion to treat itching. Action taken with mRNA-1273 in response to the events was unknown.  The outcome of the event rash ,itching were unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Red pimple rashes, some in clusters on different parts of the body including the legs and back; rashes are itchy, and her back is itching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH ERYTHEMATOUS (Red pimple rashes, some in clusters on different parts of the body including the legs and back) and RASH PRURITIC (rashes are itchy, and her back is itching) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension, High cholesterol and Hypothyroidism. Concomitant products included ATORVASTATIN for High cholesterol, METOPROLOL TARTRATE (LOPRESSOR) for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red pimple rashes, some in clusters on different parts of the body including the legs and back) and RASH PRURITIC (rashes are itchy, and her back is itching). At the time of the report, RASH ERYTHEMATOUS (Red pimple rashes, some in clusters on different parts of the body including the legs and back) and RASH PRURITIC (rashes are itchy, and her back is itching) had resolved.            Treatment included cream to put on twice a day prescribed by a Dermatologist.   This case was linked to MOD-2021-020646 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Received follow-up information. Events outcome has been updated from unknown to recovered and treatment information added.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema
Clinical narrative: arm soreness; injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and VACCINATION SITE ERYTHEMA (injection site redness) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness) and VACCINATION SITE ERYTHEMA (injection site redness). At the time of the report, PAIN IN EXTREMITY (arm soreness) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity
Clinical narrative: foot pain; knee pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (foot pain) and ARTHRALGIA (knee pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Femur fracture (fractures in her femur from a fall) in 2014 and Foot surgery in 2014. Concurrent medical conditions included Knee arthritis. Concomitant products included MULTI VITAMINS & MINERALS for an unknown indication.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (foot pain) and ARTHRALGIA (knee pain). At the time of the report, PAIN IN EXTREMITY (foot pain) and ARTHRALGIA (knee pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pruritus, Rash erythematous, Vaccination site reaction
Clinical narrative: COVID ARM; Red rash that lingers on for a while/ Red big rash; Itchy; Hurting; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced HEADACHE (Headaches). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.    This case was linked to MOD-2021-094117 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Rash, Tremor
Clinical narrative: Shaking; Soreness; Small rash on buttocks; Headaches; Chills; This spontaneous case was reported by a consumer and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swelling face
Clinical narrative: low grade fever; Facial Swelling; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Facial Swelling) and PYREXIA (low grade fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062G20A) for COVID-19 vaccination.     The patient's past medical history included Eye laser surgery. Concomitant products included DEXAMETHASONE, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOMYCIN / POLY B / DEXAMETHASONE) for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced SWELLING FACE (Facial Swelling). On an unknown date, the patient experienced PYREXIA (low grade fever). On 10-Feb-2021, SWELLING FACE (Facial Swelling) had resolved. At the time of the report, PYREXIA (low grade fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up was received on 14-Jul-2021, new event low grade  fever was  added.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Itching on and off; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching on and off) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced PRURITUS (Itching on and off). At the time of the report, PRURITUS (Itching on and off) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Myocardial infarction, Vaccination site rash
Clinical narrative: Vaccination site rash; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Vaccination site rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced VACCINATION SITE RASH (Vaccination site rash). At the time of the report, VACCINATION SITE RASH (Vaccination site rash) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Myocardial infarction: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Side-effects after vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side-effects after vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side-effects after vaccination). At the time of the report, VACCINATION COMPLICATION (Side-effects after vaccination) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment medications were unknown.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up received on 20-APR-2021 included: Event outcome changed from unknown to resolving.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity
Clinical narrative: Nauseous; Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and NAUSEA (Nauseous) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis. Concurrent medical conditions included Hypertension and Hyperlipidemia. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for Hyperlipidemia, LISINOPRIL for Hypertension, TESTOSTERONE and CYANOCOBALAMIN (VITAMIN B 12 [CYANOCOBALAMIN]).    On 20-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 21-Feb-2021, the patient experienced NAUSEA (Nauseous). The patient was treated with IBUPROFEN at a dose of UNK dosage form. On 21-Feb-2021, NAUSEA (Nauseous) had resolved. At the time of the report, PAIN IN EXTREMITY (Arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pain, Pyrexia
Clinical narrative: Nausea; Chills; Low grade fever; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), CHILLS (Chills), PYREXIA (Low grade fever) and PAIN (Body ache) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced NAUSEA (Nausea), CHILLS (Chills), PYREXIA (Low grade fever) and PAIN (Body ache). At the time of the report, NAUSEA (Nausea), CHILLS (Chills), PYREXIA (Low grade fever) and PAIN (Body ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and RASH (Rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PRURITUS (Itching) and RASH (Rash). At the time of the report, PRURITUS (Itching) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter. Treatment information was not provided.   This case was linked to -MOD-2021-092534 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: Follow-up received on 27-Apr-2021 included no new information.; Sender's Comments:  -MOD-2021-092534:2nd dose case
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Swelling at vaccination site; my arm was sore; hotness where shot was given; red rash encircling the area where the shot was given; This spontaneous case was reported by a consumer and describes the occurrence of   in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029l20a) for COVID-19 vaccination.     Concurrent medical conditions included White blood cell abnormalities.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Nausea, Pyrexia
Clinical narrative: Chills; Fever 102 °F; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever 102 °F) and NAUSEA (nausea) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unk) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), PYREXIA (Fever 102 °F) and NAUSEA (nausea). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, CHILLS (Chills), PYREXIA (Fever 102 °F) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pharyngeal swelling
Clinical narrative: sore throat; it hurts when he swallows; he had a lot of pain; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), PHARYNGEAL SWELLING (it hurts when he swallows) and OROPHARYNGEAL PAIN (he had a lot of pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), PHARYNGEAL SWELLING (it hurts when he swallows) and OROPHARYNGEAL PAIN (he had a lot of pain). The patient was treated with AMOXICILLIN TRIHYDRATE, CLAVULANATE POTASSIUM (AMOXICILLIN & CLAV. POTASSIUM) ongoing from 19-Feb-2021 at a dose of UNK dosage form. At the time of the report, OROPHARYNGEAL PAIN (sore throat), PHARYNGEAL SWELLING (it hurts when he swallows) and OROPHARYNGEAL PAIN (he had a lot of pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Tenderness, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Red skin scarring; Tenderness - Near Vaccination  Site; Redness - NearVccination Site; Swelling - Near Vaccination Site; Hot to Touch Sensation - Near vaccination Site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), ERYTHEMA (Red skin scarring), TENDERNESS (Tenderness - Near Vaccination  Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     Concurrent medical conditions included Bigeminy, Hypertension, Type II diabetes mellitus, Shellfish allergy and Drug allergy. Concomitant products included HCTZ, METFORMIN, ATORVASTATIN CALCIUM (LIPITOR) and ATENOLOL for an unknown indication.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), TENDERNESS (Tenderness - Near Vaccination  Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site). On 09-Feb-2021, the patient experienced ERYTHEMA (Red skin scarring). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) (oral) for Adverse event, at a dose of 1-2, prn and CEFALEXIN for Adverse event, at an unspecified dose and frequency. On 06-Mar-2021, VACCINATION SITE WARMTH (Hot to Touch Sensation - Near vaccination Site), ERYTHEMA (Red skin scarring), TENDERNESS (Tenderness - Near Vaccination  Site), VACCINATION SITE ERYTHEMA (Redness - NearVccination Site) and VACCINATION SITE SWELLING (Swelling - Near Vaccination Site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-259356 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14-JUL-2021 contains patient demographic information, race information, medical history, concomitant drugs information.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Vision blurred
Clinical narrative: General body pain; Blurry vision; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (General body pain), NAUSEA (Nausea) and VISION BLURRED (Blurry vision) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included METFORMIN for Blood pressure.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (General body pain), NAUSEA (Nausea) and VISION BLURRED (Blurry vision). At the time of the report, PAIN (General body pain), NAUSEA (Nausea) and VISION BLURRED (Blurry vision) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Pain in arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis. Concomitant products included PARACETAMOL (TYLENOL) for Rheumatoid arthritis.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 21-Feb-2021, PAIN IN EXTREMITY (Pain in arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced FATIGUE (tiredness). The patient was treated with PARACETAMOL (TYLENOL) for Tiredness, at an unspecified dose and frequency. At the time of the report, FATIGUE (tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Patient reported that he received second dose of Pfizer and experienced adverse events.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Erythema, Headache
Clinical narrative: Heart rate increased; Weakness; Ache; Pain in arm; Redness; Swelling arm; Dizziness; Chills; Throat tightness; Fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness) and PAIN (Ache) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031LZ0A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Tested positive for antibodies in November 2020. Waited 90 days before receiving the vaccine. ) in October 2020. Concurrent medical conditions included Shellfish allergy.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness). The patient was treated with DIPHENHYDRAMINE, PARACETAMOL (EXTRA STRENGTH TYLENOL PM) at a dose of UNK dosage form. At the time of the report, PYREXIA (Fever), HEART RATE INCREASED (Heart rate increased), HEADACHE (Headache), ASTHENIA (Weakness), PAIN (Ache), PAIN IN EXTREMITY (Pain in arm), ERYTHEMA (Redness), PERIPHERAL SWELLING (Swelling arm), DIZZINESS (Dizziness), CHILLS (Chills) and THROAT TIGHTNESS (Throat tightness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.